Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-1,003,801
Closed -$2.22M 648
2025
Q1
$2.22M Sell
1,003,801
-264,297
-21% -$970K 0.05% 419
2024
Q4
$5.25M Buy
+1,268,098
New +$3.82M 0.12% 316
2024
Q2
Sell
-39,631
Closed -$434K 735
2024
Q1
$434K Buy
39,631
+2,377
+6% +$14.2K 0.01% 665
2023
Q4
$137K Sell
37,254
-289
-0.8% -$730 ﹤0.01% 677
2023
Q3
$116K Sell
37,543
-42,897
-53% -$196K ﹤0.01% 666
2023
Q2
$384K Buy
80,440
+31,146
+63% +$172K 0.01% 618
2023
Q1
$213K Buy
49,294
+249
+0.5% +$1.59K 0.01% 603
2022
Q4
$242K Buy
49,045
+3,501
+8% +$43.5K 0.01% 591
2022
Q3
$767K Sell
45,544
-32,836
-42% -$603K 0.02% 514
2022
Q2
$752K Buy
+78,380
New +$1.31M 0.02% 505

Other funds holding NOTV

Kennedy Capital Management's NOTV Position: Q2 2025 in Review

Kennedy Capital Management sold out of Inotiv (NOTV) in Q2 2025, closing a stake of 1,003,801 shares — an estimated $2.22M sold.

Kennedy Capital Management first reported a position in NOTV in Q2 2022 and held it in 10 quarters. The position peaked at $5.25M in Q4 2024. 74 funds tracked by Wall St. Rank hold NOTV as of Q2 2025.

  • Kennedy Capital Management reported no remaining Inotiv position as of Q2 2025 after selling out during the quarter.
  • Kennedy Capital Management sold 1,003,801 Inotiv shares in Q2 2025, an estimated $2.22M.
  • Kennedy Capital Management first reported a position in Inotiv in Q2 2022 and held it in 10 quarters.
  • Kennedy Capital Management's Inotiv position peaked at $5.25M in Q4 2024.
  • 74 funds tracked by Wall St. Rank held Inotiv as of Q2 2025.

Based on Kennedy Capital Management's 13F filing for Q2 2025, filed 13 Aug 2025.